Safety, Efficacy, and Clinical Impact of Penicillin Skin Testing in Immunocompromised Cancer Patients

This publication has 23 references indexed in Scilit:

• Penicillin allergy as a public health measure
  Journal of Allergy and Clinical Immunology, 2014
• Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort study
  Journal of Allergy and Clinical Immunology, 2014
• Antibiotic Hypersensitivity Reactions and Approaches to Desensitization
  Clinical Infectious Diseases, 2013
• Safely Diagnosing Clinically Significant Penicillin Allergy Using Only Penicilloyl-Poly-Lysine, Penicillin, and Oral Amoxicillin
  The Journal of Allergy and Clinical Immunology: In Practice, 2013
• Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
  Clinical Infectious Diseases, 2011
• Drug Allergy: An Updated Practice Parameter
  Annals of Allergy, Asthma & Immunology, 2010
• Clostridium difficile and fluoroquinolones: is there a link?
  International Journal of Antimicrobial Agents, 2009
• Clinical history as a predictor of penicillin skin test outcome
  Annals of Allergy, Asthma & Immunology, 2006
• A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
  New England Journal of Medicine, 2005
• Role of Environmental Contamination as a Risk Factor for Acquisition of Vancomycin-Resistant Enterococci in Patients Treated in a Medical Intensive Care Unit
  Archives of internal medicine (1960), 2003